GW Pharmaceuticals Plc (NASDAQ:GWPH)’s stock has been of interest for both individual investors and Wall Street analysts recently. Let’s look at the crowd and equity research sentiment so that we can get a solid idea as to where the shares might be headed. Should we buy, sell or hold?

Zacks collects broker services based on the information provided by 7 analysts. These services are then Zacks into their five-point ratings scale, allowing for easier interpretation for private investors. This differs from the Crowd Ratings scale, because Zacks numbers work in the opposite direction. Zacks says one is a “Strong Buy” and five is a Strong Sell. GW Pharmaceuticals Plc (NASDAQ:GWPH)’s ABR (average broker rating) is 1.64.

Street analysts anticipate that the social media giant would post quarterly share earnings of $-1.48. The actual earnings that the firm reported last quarter was $-0.73. Interested parties will be awaiting the moment when GW Pharmaceuticals Plc (NASDAQ:GWPH) will reveal their actual results on 2016-12-05.

Now let’s look at the Closing Bell. Individual investors can rate a stock according a sliding scale where “one” is a Strong Sell and “five” is a Strong Buy. GW Pharmaceuticals Plc (NASDAQ:GWPH)’s crowd consensus rating is 3.29. This rating is derived from the 7 ratings provided by individuals investors.

Brokerage Firm Analysts View

Private investors also pay attention to how Wall Street researchers react to stocks. Zacks Research, a well-respected research firm with over 30 years of experience, compiles all of this brokerage data and then produce rankings and predictive data. Wall Street sell-side analysts anticipated that GW Pharmaceuticals Plc (NASDAQ:GWPH)’s shares will reach a high of $40-$182. The consensus target is at $140.857.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings with MarketBeat.com’s FREE daily email newsletter.